Post-doctoral position on the immune targeting of myeloma at CRCT-Toulouse (France)
A postdoctoral position, with salary funded for two years, will be available in January 2017 in the myeloma immune targeting group of the Cancer research center of Toulouse (team 13, CRCT) managed by a young PI, Dr. Ludovic Martinet (Inserm CR1).
The candidate will investigate the role of cytotoxic lymphocytes in multiple myeloma immunosurveillance and therapy using a complementary set of experimental approaches involving both human samples and relevant mouse models.
We seek highly motivated scientists who hold a Ph.D in immunology with strong background in cellular immunology and experience of mouse models. Good track record, technical and organizational skills are expected.
The position is for 2 years, available immediately, with the possibility of one year extension. The application should contain a motivation letter, CV and contact details of two referees.
The Cancer Research Center of Toulouse (CRCT) gathers 250 scientists from 3 public research institutions (Inserm UMR1037, Université Paul Sabatier-Toulouse III and CNRS ERL5294) that have joined their efforts to launch innovative researches against cancer. The CRCT is equipped with the most recent technological tools and platforms including fully automated animal facility, flow cytometry platform, imaging platform and Next generation sequencing platform (see www.CRCT-inserm.fr).
For further information and to apply, please see the full offer description:
Deadline: January 2017